Sandy Draper
Stock Analyst at Guggenheim
(2.91)
# 1,432
Out of 5,154 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $469.38 | -7.96% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $3.40 | +723.53% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $178.50 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $181.32 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.29 | +336.68% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $26.07 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.85 | -29.82% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $110.60 | +137.79% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.66 | +4,414.67% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $79.96 | +17.57% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $5.12 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.84 | +113.93% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $197.14 | -34.56% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $34.68 | +58.59% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $103.32 | +62.60% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $15.88 | -24.43% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $8.56 | +484.11% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $9.13 | +611.94% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $1.93 | +1,765.28% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $196.06 | -14.82% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.85 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $8.12 | +675.86% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $469.38
Upside: -7.96%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $3.40
Upside: +723.53%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $178.50
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $181.32
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.29
Upside: +336.68%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $26.07
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.85
Upside: -29.82%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $110.60
Upside: +137.79%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.66
Upside: +4,414.67%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $79.96
Upside: +17.57%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $5.12
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.84
Upside: +113.93%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $197.14
Upside: -34.56%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $34.68
Upside: +58.59%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $103.32
Upside: +62.60%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $15.88
Upside: -24.43%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $8.56
Upside: +484.11%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $9.13
Upside: +611.94%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $1.93
Upside: +1,765.28%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $196.06
Upside: -14.82%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.85
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $8.12
Upside: +675.86%